Cannabis only increased psychosis risk in people who already had elevated inflammation, supporting a "two-hit" model

Daily cannabis use and early onset (before age 17) were only associated with psychosis among individuals with medium-to-high systemic inflammation, providing the first human evidence for a two-hit hypothesis.

Corsi-Zuelli, Fabiana et al.·Psychological medicine·2021·Moderate EvidenceCross-Sectional
RTHC-03075Cross SectionalModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Cannabis did not increase inflammation (ruling out a mediating pathway). Instead, daily cannabis use and onset before age 17 only increased psychosis odds among those with medium-to-high inflammatory composite scores. This interaction effect went beyond the individual effects of either cannabis or inflammation alone.

Key Numbers

153 first-episode psychosis patients; 256 controls; 7 cytokines measured; daily use and onset <17 interacted with inflammation; cannabis did not increase inflammation directly

How They Did This

Cross-sectional study of 153 first-episode psychosis patients and 256 community controls. Cannabis use assessed via Cannabis Experience Questionnaire. Seven plasma cytokines measured to create an inflammatory composite score. Mediation and moderation analyses performed.

Why This Research Matters

This suggests not everyone who uses cannabis faces equal psychosis risk. Pre-existing immune dysregulation may be a necessary biological vulnerability that cannabis then triggers, explaining why most users never develop psychosis.

The Bigger Picture

The two-hit hypothesis could eventually enable personalized risk assessment: measuring inflammatory markers might identify individuals for whom cannabis poses a genuine psychosis risk versus those for whom it does not.

What This Study Doesn't Tell Us

Cross-sectional design cannot confirm temporal ordering. Single blood inflammatory measurement. Cannot rule out unmeasured confounders. First-episode psychosis patients may differ from the broader at-risk population.

Questions This Raises

  • ?Could inflammatory biomarkers be used to screen for cannabis-psychosis vulnerability?
  • ?Would anti-inflammatory treatments reduce psychosis risk in cannabis users with high inflammation?
  • ?Is the inflammation genetic, environmental, or both?

Trust & Context

Key Stat:
Daily cannabis use only linked to psychosis in those with medium-to-high inflammation
Evidence Grade:
Well-designed cross-sectional study with biological measures, though cannot establish temporal causation
Study Age:
Published in 2021. The two-hit hypothesis for cannabis and psychosis is an emerging area of research.
Original Title:
The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis.
Published In:
Psychological medicine, 1-11 (2021)
Database ID:
RTHC-03075

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Why do some cannabis users develop psychosis and others do not?

This study found cannabis only increased psychosis risk in people with pre-existing elevated inflammation. Those with low inflammation who used cannabis did not show increased risk, supporting the idea that a biological vulnerability is needed.

Does cannabis cause inflammation that leads to psychosis?

No. This study found cannabis did not increase inflammation. Instead, pre-existing immune dysregulation appeared to be the vulnerability that cannabis then interacted with to increase psychosis risk.

Read More on RethinkTHC

Cite This Study

RTHC-03075·https://rethinkthc.com/research/RTHC-03075

APA

Corsi-Zuelli, Fabiana; Marques, Leonardo; da Roza, Daiane Leite; Loureiro, Camila Marcelino; Shuhama, Rosana; Di Forti, Marta; Menezes, Paulo Rossi; Louzada-Junior, Paulo; Del-Ben, Cristina Marta. (2021). The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis.. Psychological medicine, 1-11. https://doi.org/10.1017/S0033291721000726

MLA

Corsi-Zuelli, Fabiana, et al. "The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis.." Psychological medicine, 2021. https://doi.org/10.1017/S0033291721000726

RethinkTHC

RethinkTHC Research Database. "The independent and combined effects of cannabis use and sys..." RTHC-03075. Retrieved from https://rethinkthc.com/research/corsi-zuelli-2021-the-independent-and-combined

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.